We are live on !
Find out more
Emerald Advisers Portfolio holdings
AUM
$4.25B
Turnover
24.28%
1-Year Est. Return
141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
(+34%)
Cap. Flow
-$109M
Cap. Flow % of AUM
Cap. Flow %
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39
Avg Time Held
2.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Legence Corp
LGN
|
+$53.3M |
| 2 |
Sensient Technologies
SXT
|
+$43.9M |
| 3 |
InterDigital
IDCC
|
+$35.5M |
| 4 |
Axcelis
ACLS
|
+$34.7M |
| 5 |
Terex
TEX
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$137M |
| 2 |
Credo Technology Group
CRDO
|
+$94.7M |
| 3 |
TTM Technologies
TTMI
|
+$85.3M |
| 4 |
Fabrinet
FN
|
+$68.7M |
| 5 |
Sterling Infrastructure
STRL
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Industrials | 23.28% |
| 3 | Healthcare | 21.93% |
| 4 | Financials | 9.1% |
| 5 | Consumer Discretionary | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Travere Therapeutics
TVTX
$4.68B
| $90.9M | 2.14% |
1,600,886
+43,690
| +3% | +$1.94M |
2023 Q2
12 quarters
|
|
2
Cardinal Infrastructure Group
CDNL
$313M
| $79.9M | 1.88% |
847,969
+269,369
| +47% | +$15.5M |
2025 Q4
2 quarters
|
|
3
Mercury Systems
MRCY
$4.52B
| $78.1M | 1.84% |
638,682
+43,368
| +7% | +$4.13M |
2025 Q2
4 quarters
|
|
4
AAR Corp
AIR
$3.97B
| $74.6M | 1.76% |
521,919
+76,226
| +17% | +$9M |
2023 Q2
12 quarters
|
|
5
VSE Corp
VSEC
$4.6B
| $73.8M | 1.74% |
323,152
+8,363
| +3% | +$1.61M |
2025 Q1
5 quarters
|
|
6
Kulicke & Soffa
KLIC
$4.11B
| $73.8M | 1.74% |
551,535
-17,461
| -3% | -$1.71M |
2023 Q4
10 quarters
|
|
7
Argan
AGX
$4.85B
| $71.3M | 1.68% |
89,296
-5,976
| -6% | -$3.98M |
2025 Q3
3 quarters
|
|
8
Ceco Environmental
CECO
$3.32B
| $66.9M | 1.57% |
736,784
+213,767
| +41% | +$16.9M |
2025 Q3
3 quarters
|
|
9
Corcept Therapeutics
CORT
$11.9B
| $65.1M | 1.53% |
748,325
+542,767
| +264% | +$32.8M |
2025 Q1
5 quarters
|
|
10
LivaNova
LIVN
$4.27B
| $64.7M | 1.52% |
787,101
+116,894
| +17% | +$8.27M |
2023 Q1
13 quarters
|
|
11
Semtech
SMTC
$12.8B
| $63.6M | 1.5% |
393,030
-63,988
| -14% | -$8.36M |
2025 Q3
3 quarters
|
|
|
12
InterDigital
IDCC
$8.24B
| $63.3M | 1.49% |
223,517
+119,452
| +115% | +$35.5M |
2024 Q1
9 quarters
|
|
13
ESCO Technologies
ESE
$6.45B
| $62.9M | 1.48% |
179,798
+17,145
| +11% | +$5.36M |
2025 Q2
4 quarters
|
|
|
14
Axcelis
ACLS
$3.35B
| $62.6M | 1.47% |
330,469
+234,231
| +243% | +$34.7M |
2026 Q1
1 quarter
|
|
15
PDF Solutions
PDFS
$1.66B
| $62.6M | 1.47% |
884,294
+23,475
| +3% | +$1.16M |
2022 Q2
16 quarters
|
|
16
Plexus
PLXS
$6.14B
| $62.5M | 1.47% |
207,712
+41,180
| +25% | +$10.7M |
2026 Q1
1 quarter
|
|
17
Cohu
COHU
$2.41B
| $62.4M | 1.47% |
843,627
+63,528
| +8% | +$3.18M |
2026 Q1
1 quarter
|
|
18
Cogent Biosciences
COGT
$5.12B
| $62M | 1.46% |
1,603,319
+15,187
| +1% | +$531K |
2025 Q2
4 quarters
|
|
19
Allegiant Air
ALGT
$1.83B
| $55.9M | 1.32% |
475,112
+137,079
| +41% | +$11.9M |
2024 Q4
6 quarters
|
|
|
20
Legence Corp
LGN
$3.35B
| $55.7M | 1.31% |
+653,788
| New | +$53.3M |
2026 Q2
0 quarters
|
|
21
Mirum Pharmaceuticals
MIRM
$5.2B
| $54.8M | 1.29% |
468,295
+71,032
| +18% | +$7.13M |
2025 Q2
4 quarters
|
|
22
Guardant Health
GH
$21.3B
| $54.6M | 1.29% |
364,022
-477,895
| -57% | -$52M |
2025 Q1
5 quarters
|
|
23
Modine Manufacturing
MOD
$7.91B
| $54.1M | 1.27% |
202,754
-175,364
| -46% | -$46.2M |
2024 Q2
8 quarters
|
|
24
Axos Financial
AX
$5B
| $52.2M | 1.23% |
536,162
+39,930
| +8% | +$3.6M |
2023 Q1
13 quarters
|
|
25
Solaris Energy Infrastructure
SEI
$4.13B
| $51.5M | 1.21% |
640,616
+45,929
| +8% | +$3.28M |
2024 Q4
6 quarters
|
|
Similar funds
AP
SCA
CAM
Emerald Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.
- Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
- Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
- Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
- Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
- Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
- Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
- Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.
Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.